PMID- 22650374 OWN - NLM STAT- MEDLINE DCOM- 20130801 LR - 20190907 IS - 1873-4294 (Electronic) IS - 1568-0266 (Linking) VI - 12 IP - 13 DP - 2012 TI - TNF-alpha inhibitors with anti-oxidative stress activity from natural products. PG - 1408-21 AB - Tumor necrosis factor-alpha (TNF-alpha) is a major cytokine involved in the inflammatory response. Elevated TNF-alpha expression has been found to be associated with the development of diabetes, septic shock, tumorigenesis, cardiovascular diseases, rheumatoid arthritis and inflammatory bowel disease. In the past decade, the success of anti-TNF-alpha biologics has valuated the importance of the blockade of TNF-alpha production in the treatment of patients with various inflammatory diseases. Oxidative stress is another important element in oxidative/inflammatory responses that directly linked to oxidation of proteins, DNA and lipids. The increased oxidant levels could activate nuclear factor-kappaB (NFkappa-B), signal transduction and gene expression of TNF-alpha, interleukin-1 (IL-1) and other pro-inflammatory cytokines. Therefore, TNF-alpha inhibitors with anti-oxidative stress activity may have multiple target effect that could exhibit excellent anti-inflammatory activities. The review briefly highlights the pathological roles of TNF-alpha and oxidative stress in inflammation, and covers those natural products as TNF-alpha inhibitors capable of anti-oxidative stress activity. FAU - Li, Jing AU - Li J AD - School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China. lij@scut.edu.cn FAU - Zhang, Huibin AU - Zhang H FAU - Huang, Wenlong AU - Huang W FAU - Qian, Hai AU - Qian H FAU - Li, Ying AU - Li Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review PL - United Arab Emirates TA - Curr Top Med Chem JT - Current topics in medicinal chemistry JID - 101119673 RN - 0 (Biological Products) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Biological Products/chemistry/*pharmacology MH - Humans MH - Inflammation/drug therapy MH - Molecular Structure MH - Oxidative Stress/*drug effects MH - Signal Transduction/drug effects MH - Tumor Necrosis Factor-alpha/*antagonists & inhibitors/genetics/metabolism EDAT- 2012/06/02 06:00 MHDA- 2013/08/02 06:00 CRDT- 2012/06/02 06:00 PHST- 2009/11/11 00:00 [received] PHST- 2011/10/24 00:00 [accepted] PHST- 2012/06/02 06:00 [entrez] PHST- 2012/06/02 06:00 [pubmed] PHST- 2013/08/02 06:00 [medline] AID - CTMC-EPUB-20120531-3 [pii] AID - 10.2174/156802612801784434 [doi] PST - ppublish SO - Curr Top Med Chem. 2012;12(13):1408-21. doi: 10.2174/156802612801784434.